| Patent application number | Description | Published |
|---|
| 20090036704 | Process for Preparing 4-Pentafluorosulfanylbenzoylguanidines - A process for preparing 4-pentafluorosulfanylbenzoylguanidines of formula I | 02-05-2009 |
| 20090143473 | USE OF INHIBITORS OF THE CELLULAR NA+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS - Use of inhibitors of the cellular Na | 06-04-2009 |
| 20090203761 | PROCESS FOR PREPARING (3-OXO-2,3-DIHYDRO-1H-ISOINDOL-1-YL) ACETYLGUANIDINE DERIVATIVES - The present invention relates to processes for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetylguanidine derivatives of the formula I | 08-13-2009 |
| 20100016272 | HETEROARYLACRYLAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to heteroarylacrylamides of the formula I, | 01-21-2010 |
| 20100016337 | HETEROARYL-SUBSTITUTED CARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to heteroaryl-substituted carboxamides of the formula I, | 01-21-2010 |
| 20100204206 | Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them - Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them | 08-12-2010 |
| 20110015167 | USE OF NORGESTIMATE AS A SELECTIVE INHIBITOR OF TRPC3, TRPC6 AND TRPC7 ION CHANNELS - TRPC ion channels are non-selective channels widely expressed in human tissues. These channels are involved in numerous physiological functions and are putative targets for the development of novel medicines. There is a need to gain a better understanding of TRPC ion channels in cells and beyond. The present invention provides a pharmacological tool compound that allows to study TRPC ion channels due to its discriminating inhibition of TRPC subfamilies. In the present invention, norgestimate is shown to selectively inhibit TRPC3, TRPC6 and TRPC7. | 01-20-2011 |
| 20110306670 | PENTAFLUOROSULFANYLBENZOYLGUANIDINES, PROCESSES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS OR DIAGNOSTIC AIDS, AND MEDICAMENTS COMPRISING THEM - Pentafluorosulfanylbenzoylguanidines of the formula I and II | 12-15-2011 |
